» Articles » PMID: 37603220

The Role of Exosomes and Their Enhancement Strategies in the Treatment of Osteoarthritis

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2023 Aug 21
PMID 37603220
Authors
Affiliations
Soon will be listed here.
Abstract

With the increasingly prominent problem of population aging, osteoarthritis (OA), which is closely related to aging, has become a serious illness affecting the lives and health of elderly individuals. However, effective treatments are still lacking. OA is typically considered a low-grade inflammatory state. The inflammatory infiltration of macrophages, neutrophils, T cells, and other cells is common in diseased joints. These cells create the inflammatory environment of OA and are involved in the onset and progression of the disease. Exosomes, a type of complex vesicle containing abundant RNA molecules and proteins, play a crucial role in the physiological and pathological processes of an organism. In comparison to other therapeutic methods such as stem cells, exosomes have distinct advantages of precise targeting and low immunogenicity. Moreover, research and techniques related to exosomes are more mature, indicating a promising future in disease treatment. Many studies have shown that the impact of exosomes on the inflammatory microenvironment directly or indirectly leads to the occurrence of various diseases. Furthermore, exosomes can be helpful in the management of illnesses. This article provides a comprehensive review and update on the research of exosomes, a type of extracellular vesicle, in the treatment of OA by modulating the inflammatory microenvironment. It also combines innovative studies on the modification of exosomes. In general, the application of exosomes in the treatment of OA has been validated, and the introduction of modified exosome technology holds potential for enhancing its therapeutic efficacy.

Citing Articles

Knee adipose tissue: from its implication in osteoarthritis to its supposed role in tissue engineering.

Stocco E, Emmi A, De Caro R, Porzionato A, Macchi V NPJ Aging. 2025; 11(1):5.

PMID: 39900591 PMC: 11790864. DOI: 10.1038/s41514-025-00195-3.


Potential and challenges of utilizing exosomes in osteoarthritis therapy (Review).

Chen X, Tian B, Wang Y, Zheng J, Kang X Int J Mol Med. 2025; 55(3).

PMID: 39791222 PMC: 11759586. DOI: 10.3892/ijmm.2025.5484.


Roles of Microenvironment on Mesenchymal Stem Cells Therapy for Osteoarthritis.

Zhang H, Jin C, Hua J, Chen Z, Gao W, Xu W J Inflamm Res. 2024; 17:7069-7079.

PMID: 39377043 PMC: 11457791. DOI: 10.2147/JIR.S475617.

References
1.
Emami A, Namdari H, Parvizpour F, Arabpour Z . Challenges in osteoarthritis treatment. Tissue Cell. 2022; 80:101992. DOI: 10.1016/j.tice.2022.101992. View

2.
Mohd Yunus M, Nordin A, Kamal H . Pathophysiological Perspective of Osteoarthritis. Medicina (Kaunas). 2020; 56(11). PMC: 7696673. DOI: 10.3390/medicina56110614. View

3.
Perrot S . Osteoarthritis pain. Best Pract Res Clin Rheumatol. 2015; 29(1):90-7. DOI: 10.1016/j.berh.2015.04.017. View

4.
Xia B, Chen D, Zhang J, Hu S, Jin H, Tong P . Osteoarthritis pathogenesis: a review of molecular mechanisms. Calcif Tissue Int. 2014; 95(6):495-505. PMC: 4747051. DOI: 10.1007/s00223-014-9917-9. View

5.
Pereira D, Ramos E, Branco J . Osteoarthritis. Acta Med Port. 2015; 28(1):99-106. DOI: 10.20344/amp.5477. View